2024 Summer Conference | C16 - Clinical Approach to Myelopathy
| 01:20 PM - 01:47 PM EDT | Speaker |
Autoimmune/Inflammatory Myelopathies
Alfonso S. Lopez, MD |
| 01:47 PM - 02:14 PM EDT | Speaker |
Infectious Myelopathies
Tracey Cho, MD, FAAN |
| 02:14 PM - 02:41 PM EDT | Speaker |
Inflammatory Myelopathy Mimics
Kyle M. Blackburn, MD |
| 02:41 PM - 02:48 PM EDT | Abstract |
048 - Comparison of MRI Brain and Spine Lesions During Clinical Attacks and Remission in MOG Antibody-associated Disease and Multiple Sclerosis
Stephanie Syc-Mazurek, MD, PhD |
| 02:48 PM - 02:55 PM EDT | Abstract |
065 - Utility of Flexion-extension MRI to Reveal Occult Cervical Spondylotic Compression in Those with Suspected Inflammatory or Undifferentiated Myelopathies
Santiago Martinez Sosa, MBBS |
| Sean J. Pittock, MD, FAAN | Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Kyle M. Blackburn, MD | Dr. Blackburn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. |
| Jayawant N. Mandrekar, PhD | Dr. Mandrekar has nothing to disclose. |
| Shailee S. Shah, MD | Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care. |
| Santiago Martinez Sosa, MBBS | Dr. Martinez Sosa has nothing to disclose. |
| John Chen | John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. |
| Vyanka Redenbaugh, MB BCh BAO | Dr. Redenbaugh has nothing to disclose. |
| Stephanie Syc-Mazurek, MD, PhD | Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities. |
| Eoin P. Flanagan, MBBCh, FAAN | The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities. |
| Alfonso S. Lopez, MD | Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . |
| Laura Cacciaguerra, MD, PhD | Dr. Cacciaguerra has nothing to disclose. |
| Ajay Madhavan | Ajay Madhavan has nothing to disclose. |
| Elia Sechi, MD | Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. |
| Jan-Mendelt Tillema, MD | Dr. Tillema has nothing to disclose. |
| Tracey Cho, MD, FAAN | Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care. |
| Deena Tajfirouz, MD | Dr. Tajfirouz has nothing to disclose. |
| Cristina Valencia Sanchez, MD | Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Valencia Sanchez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Valencia Sanchez has a non-compensated relationship as a member of the medical advisory board with The MOG Project that is relevant to AAN interests or activities. |
| Karl Krecke | Karl Krecke has nothing to disclose. |